Cytosorbents

-$0.07 (-0.92%) As of 6:02 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO
Phillip P. Chan
Employees
195
Headquarters
Monmouth Junction, New Jersey
Founded
2002

CTSO Key Statistics

Market Cap
344.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
158.47K
High Today
$7.75
Low Today
$7.42
Open Price
$7.75
Volume
86.53K
52 Week High
$11.68
52 Week Low
$7.13

CTSO Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 3, After Hours
Preview Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure